Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
OpenUpdated: Oct 30, 2025
Summary
The purpose of this grant is to fund clinical trials that evaluate the efficacy and safety of products for new indications or labeling changes to address unmet needs in rare diseases, ultimately aiming to increase the number of approved treatments in this area. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, for-profit organizations, government entities, and foreign organizations. Application details are not specified in the provided information, but interested parties can contact Kimberly Pendleton at the FDA for further inquiries.
Full Description
Description
The purpose of this Notice of Funding Opportunity (NOFO) is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. Additionally, through the funding of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare diseases and exert a broad and positive impact on rare disease drug development.
Eligibility
Eligible applicants
Miscellaneous
- Other
Additional information
Grantor contact information
Description
Email: Kimberly.Pendleton@fda.hhs.gov
Recommended Resource
Grant Writing Services on Fiverr
Top PickStruggling with grant applications? Get expert help from professional freelance writers on Fiverr — from research and proposal drafts to compliance review and submission. Secure funding faster with proven talent.